Lv1
34 积分 2026-04-13 加入
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
1小时前
待确认
Cardio-Oncology: Managing Cardiovascular Complications of Cancer Therapies
2天前
已完结
Unveiling the Cardiotoxicity Conundrum: Navigating the Seas of Tyrosine Kinase Inhibitor Therapies
2天前
已完结
Immune Checkpoint Inhibitor–Induced Cardiotoxicity
2天前
已完结
Immune Checkpoint Inhibitor–Associated Cardiovascular Toxicity: Mechanisms, Clinical Manifestations, and Clinical Impact
2天前
已完结
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
2天前
已完结
Role of Neuregulin-1/ErbB Signaling in Cardiovascular Physiology and Disease
2天前
已完结
Inflammation in Chemotherapy-Induced Cardiotoxicity
3天前
已完结
Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies
3天前
已完结
Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury
3天前
已完结
皖公网安备34019202002308
